Mednet Logo
HomeMedical OncologyQuestion

Do you modify the duration of adjuvant therapy for patients with colon cancer who have undergone metastectomy and primary tumor resection?

1
1 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center

For de novo oligometastatic colon cancer that is amenable to a potentially curative approach, I aim for 6 months of perioperative chemotherapy with fluoropyrimidine and oxaliplatin. Since irinotecan, anti-EGFR monoclonal antibodies, and bevacizumab do not treat micrometastatic disease effectively, t...

Register or Sign In to see full answer